Brain-derived neurotrophic factor expression is increased in the rat amygdala, piriform cortex and hypothalamus following repeated amphetamine administration

Brain Research

Volumn 949, Issue 1-2, 2002, Pages 218-227

  Meredith, Gloria E ^a,b   Callen, Shannon ^a   Scheuer, Deborah A ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^b ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

Basolateral amygdala; Extended amygdala; Neurotrophin; Nucleus accumbens; Psychostimulant

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; DEXAMPHETAMINE; MESSENGER RNA;

AMYGDALOID NUCLEUS; ANIMAL BEHAVIOR; ANIMAL TISSUE; ANTERIOR HYPOTHALAMUS; ARTICLE; BRAIN REGION; CONTROLLED STUDY; CORPUS STRIATUM; FOREBRAIN; HYPERACTIVITY; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; MALE; NONHUMAN; NUCLEUS ACCUMBENS; OLFACTORY BULB; PERIKARYON; PRIORITY JOURNAL; PROTEIN EXPRESSION; PYRIFORM CORTEX; RAT; STEREOTYPY;

AMYGDALA; ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CENTRAL NERVOUS SYSTEM STIMULANTS; DEXTROAMPHETAMINE; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INJECTIONS, INTRAPERITONEAL; MALE; PROSENCEPHALON; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; UP-REGULATION;

EID: 0037072518     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(02)03160-8     Document Type: Article

References (69)

1. Alheid G.F., Heimer L. New perspectives in basal forebrain organization of special relevance for neuropsychiatric disorders: the striatopallidal, amygdaloid and corticopetal components of the substantia innominata. Neuroscience. 27:1988;1-39.
2. Altar C.A.J., Cai N., Bliven T., Juhasz M., Conner J.M., Acheson A.L., Lindsay R.M., Wiegand S.J. Anterograde transport of brain-derived neurotrophic factor and its role in the brain. Nature. 389:1997;856-860.
3. Black I.B. Trophic regulation of synaptic plasticity. J. Neurobiol. 41:1999;108-118.
4. Brog J.S., Salyapongse A., Deutch A.Y., Zahm D. The patterns of afferent innervation of the core and shell in the 'accumbens' part of the rat ventral striatum: Immunohistochemical detection of retrogradely transported fluoro-gold. J. Comp. Neurol. 338:1993;255-278.
5. Carlezon W.A. Jr., Thome J., Olson V.G., Lane-Ladd S.B., Brodkikn E.S., Hiroi N., Duman R.S., Neve R.L., Nestler E.J. Regulation of cocaine reward by CREB. Science. 282:1998;2272-2275.
6. Castren E., Thoenen H., Lindholm D. Brain-derived neurotrophic factor messenger RNA is expressed in the septum, hypothalamus and in adrenergic brain stem nuclei of adult rat brain and is increased by osmotic stimulation in the paraventricular nucleus. Neuroscience. 64:1995;71-80.
7. Chalmers J.P., Blessing W.W., West M.J., Howe P.R.C., Costa M., Furness J.B. Importance of new catecholamine pathways in control of blood pressure. Clin. Exp. Hypertens. 3:1981;393-416.
8. Conner J.M., Lauterborn J.C., Yan Q., Gall C.M., Varon S. Distribution of brain-derived neurotrophic factor (BDNF) protein and mRNA in the normal adult rat CNS: evidence for anterograde axonal transport. J. Neurosci. 17:1997;2295-2313.
9. Cornish J.L., Duffy P., Kalivas P.W. A role for nucleus accumbens glutamate transmission in the relapse to cocaine-seeking behavior. Neuroscience. 93:1999;1359-1367.
10. Dawson N.M., Hamid E., Egan M.F., Meredith G.E. Haloperidol regulation of brain-derived neurotrophic factor in the extended amygdala of the rat. Synapse. 39:2001;70-81.
11. Enfors P., Wetmore C., Olson L., Persson H. Identification of cells in rat brain and peripheral tissues expressing mRNA for members of the nerve growth factor family. Neuron. 5:1990;511-526.
12. Everitt B.J., Morris K.A., O'Brien A., Robbins T.W. The basolateral amygdala-ventral striatal system and conditioned place preferences: further evidence of limbic-striatal interactions underlying reward-related processes. Neuroscience. 42:1991;1-18.
13. Everitt B.J., Parkinson J.A., Olmstead M.C., Arroyo M., Robledo P., Robbins T.W. Associative processes in addiction and reward. McGinty J., Advancing from the Ventral Striatum to the Extended Amygdala: Implications for Neuropsychiatry and Drug Abuse. 1999;412-438 New York Academy of Sciences, New York.
14. Figurov A., Pozzo-Miller L.D., Olafsson P., Wang T., Lu B. Regulation of synaptic responses to high-frequency stimulation and LTP by neurotrophins in the hippocampus. Nature. 381:1996;706-709.
15. Fischman M.W., Schuster C.R., Resnekov L., Shick J.F., Krasnegor N.A., Fennell W., Freedman D.X. Cardiovascular and subjective effects of intravenous cocaine administration in humans. Arch. Gen. Psychiat. 33:1976;983-984.
16. Frey S., Bergado-Rosado J., Seidenbecher T., Pape H.-C., Uwe Frey J. Reinforcement of early long-term potentiation (early-LTP) in dentate gyrus by stimulation of the basolateral amygdala: heterosynaptic induction mechanisms of late-LTP. J. Neurosci. 21:2001;3697-3703.
17. Garcia R., Vouimba R.-M., Baudry M., Thompson R.F. The amygdala modulates prefrontal cortex activity relative to conditioned fear. Nature. 402:1999;294-296.
18. Gelowitz D.J., Kokkinidis L. Enhanced amygdala kindling after electrical stimulation of the ventral tegmental area: implications for fear and anxiety. J. Neurosci. 19:1999;1-5.
19. Grace A.A., Bunney B.S. Induction of depolarization block in midbrain dopamine neurons by repeated administration of haloperidol: analysis using in vivo intracellular recording. J. Pharmacol. Exp. Ther. 238:1986;1092-1100.
20. Guarraci F.A., Frohardt R.J., Kapp B.S. Amygdaloid D1 receptor involvement in Pavlovian fear conditioning. Brain Res. 827:1999;28-40.
21. Horger B.A., Iyasere C.A., Berhow M.T., Messer C.J., Nestler E.J., Taylor J.R. Enhancement of locomotor activity and conditioned reward to cocaine by brain-derived neurotrophic factor. J. Neurosci. 19:1999;4110-4122.
22. Hurd Y.L., McGregor A., Pontén M. In vivo amygdala dopamine levels modulate cocaine self-administration behaviour in the rat: D1 dopamine receptor involvement. Eur. J. Neurosci. 9:1997;2541-2548.
23. Hyman C., Hoffer M., Barde Y.-A., Juhasz M., Yancopoulos G.D., Squinto S.P., Lindsay R.M. BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature. 363:1991;266-270.
24. Ikegaya Y., Saito H., Abe K. Requirement of basolateral amygdala neuron activity for the induction of long-term potentiation in the dentate gyrus in vivo. Brain Res. 671:1995;351-354.
25. Kalivas P.W., Alesdatter J.E. Involvement of NMDA receptor stimulation in the VTA and amygdala in behavioral sensitization to cocaine. J. Pharmacol. Exp. Ther. 267:1993;486-495.
26. Kalivas P.W., Stewart J. Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res. Rev. 16:1991;223-244.
27. Korte M., Carroll P., Wolf E., Brem G., Thoenen H., Bonhoeffer T. Hippocampal long-term potentiation is impaired in mice lacking brain-derived neurotrophic factor. Proc. Natl. Acad. Sci. USA. 92:1995;8856-8860.
28. Korte M., Griesbeck O., Gravel C., Carroll P., Staiger V., Thoenen H., Bonhoeffer T. Virus-mediated gene transfer into hippocampal CA1 region restores long-term potentiation in brain-derived neurotrophic factor mutant mice. Proc. Natl. Acad. Sci. USA. 93:1996;12547-12552.
29. Krettek J.E., Price J.L. Amygdaloid projections to subcortical structures within the basal forebrain and brainstem in the rat and cat. J. Comp. Neurol. 178:1978;225-254.
30. LeDoux J.E. Emotion circuits in the brain. Ann. Rev. Neurosci. 23:2000;155-184.
31. Lin S.-Y., Wu K., Len G.-W., Xu J.-L., Levine E.S., Suen P.-C., Mount H.T.J., Black I.B. Brain-derived neurotrophic factor enhances association of protein tyrosine phosphatase PTP1D with the NMDA receptor subunit NR2B in the cortical postsynaptic density. Mol. Brain Res. 70:1999;18-25.
32. Linder J.C., Young S.J., Groves P.M. Electron microscopic evidence for neurotoxicity in the basal ganglia. Neurochem. Intl. 26:1995;195-202.
33. Maren S., Fanselow M.S. Synaptic plasticity in the basolateral amygdala induced by hippocampal formation stimulation in vivo. J. Neurosci. 15:1995;7548-7564.
34. Martin D.S., Haywood J.R. Sympathetic nervous system activation by glutamate injections into the paraventricular nucleus. Brain Res. 577:1992;261-267.
35. McDonald A.J. Neuronal organization of the lateral and basolateral amygdaloid nuclei in the rat. J. Comp. Neurol. 222:1984;589-606.
36. Meil W.M., See R.E. Lesions of the basolateral amygdala abolish the ability of drug associated cues to reinstate responding during withdrawal from self-administered cocaine. Behav. Brain Res. 87:1997;139-148.
37. Merlio J.P., Ernfors P., Jaber M., Persson H. Molecular cloning of rat trkC and distribution of cells expressing messenger RNA for members of the trk family in the rat central nervous system. Neuroscience. 51:1992;513-532.
38. Neugebauer V., Zinebi F., Russell R., Gallagher J.P., Shinnick-Gallagher P. Cocaine and kindling alter the sensitivity of group II and II metabotropic glutamate receptors in the central amygdala. J. Neurophysiol. 84:2000;759-770.
39. Nibuya M., Morinobu S., Duman R.S. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J. Neurosci. 15:1995;7539-7547.
40. Paladini C.A., Fiorillo C.D., Morikawa H., Williams J.T. Amphetamine selectively blocks inhibitory glutamate transmission in dopamine neurons. Nat. Neurosci. 4:2001;275-281.
41. Patterson S.L., Abel T., Deuel T.A., Martin K.C., Rose J.C., Kandel E.R. Recombinant BDNF rescues deficits in basal synaptic transmission and hippocampal LTP in BDNF knockout mice. Neuron. 16:1996;1137-1145.
42. Pierce R.C., Pierce-Bancroft A.F., Prasad B.M. Neurotrophin-3 contributes to the initiation of behavioral sensitization to cocaine by activating the ras/mitogen-activated protein kinase signal transduction cascade. J. Neurosci. 19:1999;8685-8695.
43. Pikkarainen M., Pitkänen A. Projections from the lateral, basal and accessory basal nuclei of the amygdala to the perirhinal and postrhinal cortices in rat. Cereb. Cortex. 11:2001;1064-1082.
44. Pikkarainen M., Rönkkö S., Savander V., Insausti R., Pitkänen A. Projections from the lateral, basal and accessory basal nuclei of the amygdala to the hippocampal formation in rat. J. Comp. Neurol. 403:1999;229-260.
45. A. Pitkänen, Connectivity of the rat amygdaloid complex, in: J.P. Aggleton (Ed.), The Amygdala, A Functional Analysis, Oxford University Press, Oxford, pp. 31-116.
46. Porrino L.J., Lucignani G., Dow-Edwards D., Sokoloff L. Correlation of dose-dependent effects of acute amphetamine administration on behavior and local cerebral metabolism in rats. Brain Res. 307:1984;311-320.
47. Ragsdale C.W., Graybiel A.M. Fibers from the basolateral nucleus of the amygdala selectively innervate striosomes in the caudate nucleus of the cat. J. Comp. Neurol. 269:1988;506-522.
48. Randrup A., Munkvad I. Various forms of stereotypic activity produced by amphetamine in certain animal species and man. Neuropsychopharmacology. 127:1967;1224-1225.
49. Roberts B.L., Scheuer D., Meredith G.E. Brain-derived neurotrophic factor (BDNF) expression is upregulated in the rat amygdala following chronic amphetamine treatment. Soc. Neurosci. Absts. 27:2001;903.
50. See R.E., Kruzich P.J., Grimm J.W. Dopamine, but not glutamate, receptor blockade in the basolateral amygdala attenuates conditioned reward in a rat model of relapse to cocaine-seeking behavior. Psychopharmacologia. 154:2001;301-310.
51. Shi W.-X., Pun C.-L., Zhang X.-X., Jones M.D., Bunney B.S. Dual effects of D-amphetamine on dopamine neurons mediated by dopamine and nondopamine receptors. J. Neurosci. 20:2000;3504-3511.
52. Shieh P.B., Ghosh A. Molecular mechanisms underlying activity-dependent regulation of BDNF expression. J. Neurobiol. 41:1999;127-134.
53. Shipley M.T., Ennis M. Functional organization of the olfactory system. J. Neurobiol. 30:1996;123-176.
54. Simpson J.N., Wang J.Q., McGinty J.F. Repeated amphetamine administration induces a prolonged augmentation of phosphorylated cyclase response element-binding protein and Fos-related antigen immunoreactivity in rat striatum. Neuroscience. 69:1995;441-457.
55. Smith A.J.W., McGinty J.F. Acute amphetamine or methamphetamine alters opioid peptide mRNA expression in rat stratum. Mol. Brain Res. 21:1994;359-362.
56. Swanson L.W. The projections of the ventral tegmental area and adjacent regions: a combined fluorescence retrograde tracer and immunofluorescence study in the rat. Brain Res. Bull. 9:1982;321-353.
57. 2+ influx regulates BDNF transcription by a CREB family transcription factor-dependent mechanism. Neuron. 20:1998;709-726.
58. Thoenen H. Neurotrophins and neuronal plasticity. Science. 270:1995;593-598.
59. Thomas K.L., Everitt B.J. Limbic-cortical-ventral striatal activation during retrieval of a discrete cocaine-associated stimulus: a cellular imaging study with γ protein kinase C expression. J. Neurosci. 21:2001;2526-2535.
60. Uslaner J., Badiani A., Norton C.S., Day H.E., Watson S.J., Akil H., Robinson T.E. Amphetamine and cocaine induce different patterns of c-fos mRNA expression in the striatum and subthalamic nucleus depending on environmental context. Eur. J. Neurosci. 13:2001;1977-1983.
61. Waddington J.L. Spontaneous orofacial movements induced in rodents by very long-term neuroleptic drug administration: phenomenology, pathophysiology and putative relationship to tardive dyskinesia. Psychopharmacology. 101:1990;431-447.
62. Waddington L.E., Kokkinidis L. Infusion of the D1 receptor antagonist SCH 23390 into the amygdala blocks fear expression in a potentiated startle paradigm. Brain Res. 795:1998;128-136.
63. Wang J.Q., McGinty J.F. Alterations in striatal zif/268, preprodynoprphin and preproenkephalin mRNA expression induced by repeated amphetamine administration in rats. Brain Res. 673:1995;262-274.
64. Weiss F., Maldonado-Vlaar C.S., Parsons L.H., Kerr T.M., Smith D.L., Ben-Shahar O. Control of cocaine-seeking behavior by drug-associated stimuli in rats: effects on recovery of extinguished operant-responding and extracellular dopamine levels in amygdala and nucleus accumbens. Proc. Natl. Acad. Sci. USA. 97:2000;4321-4326.
65. Wise R.A., Bozarth M.A. A psychomotor stimulant theory of addiction. Psychol. Rev. 94:1987;469-492.
66. Wolf M.E. The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants. Prog. Neurobiol. 54:1998;679-720.
67. Yokel R.A., Wise R.A. Increased level pressing for amphetamine after pimozide in rats: implications for a dopamine theory of reward. Science. 187:1975;547-549.
68. Zhihua Z., Horowitz L.F., Montmayeur J.-P., Snapper S., Buck L.B. Genetic tracing reveals a stereotyped sensory map in the olfactory cortex. Nature. 414:2001;173-179.
69. Zhou X.F., Rush R.A. Endogenous brain-derived neurotrophic factor is anterogradely transported in primary sensory neurons. Neuroscience. 74:1996;945-953.